Sbidian E - Search Results

1

Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7 808 patients in France.

Bataille P, Amiot A, Claudepierre P, Paris N, Neuraz A, Lerner I, Garcelon N, Rance B, Grisel O, Moreau T, Bernaux M, Audureau E, Sbidian E; AP-HP/Universities/Inserm COVID-19 Research collaboration and on behalf of ‘Entrepôt de Données de Santé’ AP-HP Consortium (appendix). Bataille P, et al. Among authors: sbidian e. Aliment Pharmacol Ther. 2020 Oct;52(7):1245-1248. doi: 10.1111/apt.16040. Aliment Pharmacol Ther. 2020. PMID: 33016546 No abstract available.

2

Risk factors for corticophobia in atopic dermatitis.

Dufresne H, Bataille P, Bellon N, Compain S, Deladrière E, Bekel L, Sbidian E, Bodemer C, Hadj-Rabia S. Dufresne H, et al. Among authors: sbidian e. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e846-e849. doi: 10.1111/jdv.16739. Epub 2020 Jul 22. J Eur Acad Dermatol Venereol. 2020. PMID: 32526095 No abstract available.

3

Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database.

Pina Vegas L, Sbidian E, Penso L, Claudepierre P. Pina Vegas L, et al. Among authors: sbidian e. Rheumatology (Oxford). 2021 Mar 2;60(3):1243-1251. doi: 10.1093/rheumatology/keaa448. Rheumatology (Oxford). 2021. PMID: 32911531

4

Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study.

Pina Vegas L, Le Corvoisier P, Penso L, Paul M, Sbidian E, Claudepierre P. Pina Vegas L, et al. Among authors: sbidian e. Rheumatology (Oxford). 2022 Apr 11;61(4):1589-1599. doi: 10.1093/rheumatology/keab522. Rheumatology (Oxford). 2022. PMID: 34244706 Free PMC article.

5

Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort.

Pina Vegas L, Sbidian E, Wendling D, Goupille P, Ferkal S, Le Corvoisier P, Ghaleh B, Luciani A, Claudepierre P. Pina Vegas L, et al. Among authors: sbidian e. Rheumatology (Oxford). 2022 Apr 11;61(4):1487-1495. doi: 10.1093/rheumatology/keab565. Rheumatology (Oxford). 2022. PMID: 34270707 Free PMC article.

6

Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database.

Pina Vegas L, Penso L, Claudepierre P, Sbidian E. Pina Vegas L, et al. Among authors: sbidian e. JAMA Dermatol. 2022 May 1;158(5):513-522. doi: 10.1001/jamadermatol.2022.0364. JAMA Dermatol. 2022. PMID: 35319735 Free PMC article.

7

Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study: Reply.

Pina Vegas L, Claudepierre P, Sbidian E. Pina Vegas L, et al. Among authors: sbidian e. Rheumatology (Oxford). 2022 Aug 3;61(8):e238-e239. doi: 10.1093/rheumatology/keac158. Rheumatology (Oxford). 2022. PMID: 35333297 No abstract available.

8

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database.

Hoisnard L, Lebrun-Vignes B, Maury S, Mahevas M, El Karoui K, Roy L, Zarour A, Michel M, Cohen JL, Amiot A, Claudepierre P, Wolkenstein P, Grimbert P, Sbidian E. Hoisnard L, et al. Among authors: sbidian e. Sci Rep. 2022 May 3;12(1):7140. doi: 10.1038/s41598-022-10777-w. Sci Rep. 2022. PMID: 35504889 Free PMC article.

9

Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study: Reply.

Pina Vegas L, Claudepierre P, Sbidian E. Pina Vegas L, et al. Among authors: sbidian e. Rheumatology (Oxford). 2022 Oct 6;61(10):e321-e322. doi: 10.1093/rheumatology/keac331. Rheumatology (Oxford). 2022. PMID: 35686890 No abstract available.

10

Paradoxical reactions and biologic agents: a French cohort study of 9303 patients.

Bataille P, Layese R, Claudepierre P, Paris N, Dubiel J, Amiot A, Sbidian E; AP-HP/Universities/Inserm COVID-19 research collaboration and on behalf of the ‘Entrepôt de Données de Santé’ AP-HP consortium. Bataille P, et al. Among authors: sbidian e. Br J Dermatol. 2022 Nov;187(5):676-683. doi: 10.1111/bjd.21716. Epub 2022 Jul 12. Br J Dermatol. 2022. PMID: 35770735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters